Clinical trials: Antibiotics Resistance

Pouchitis

Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis

• Completed
• Age: 18 to 75 years
• Phase 2
• Pill or oral medicine

Phase 2 Study Investigating the Efficacy of AMT-101 in Subjects with Chronic Antibiotic-resistant Pouchitis

Trial name

FILLMORE (NCT04741087)

Testing

AMT-101 (oral)-Dose A, AMT-101 (oral)-Dose B

Where

34 sites in United States, Belgium and 8 more

Volunteers

22 people

Sponsor

Applied Molecular Transport